Transarterial chemoembolization failure/refractoriness: JSH-LCSGJ criteria 2014 update.
Kudo M, Matsui O, Izumi N, Kadoya M, Okusaka T, Miyayama S, Yamakado K, Tsuchiya K, Ueshima K, Hiraoka A, Ikeda M, Ogasawara S, Yamashita T, Minami T; Liver Cancer Study Group of Japan.
Kudo M, et al.
Oncology. 2014;87 Suppl 1:22-31. doi: 10.1159/000368142. Epub 2014 Nov 22.
Oncology. 2014.
PMID: 25427730
Review.
In the 2010 version of the Japan Society of Hepatology (JSH) consensus-based treatment algorithm for the management of hepatocellular carcinoma (HCC), transarterial chemoembolization (TACE) failure/refractoriness was defined assuming the use of superselective lipiodol TACE, which …
In the 2010 version of the Japan Society of Hepatology (JSH) consensus-based treatment algorithm for the management of hepatocellular carcin …